These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3122535)

  • 1. Increase of in vivo and in vitro production of polyclonal IgA in patients and their family members with IgA nephropathy.
    Sakai H; Nomoto Y; Tomino Y; Endoh M; Miura M; Suga T
    Adv Exp Med Biol; 1987; 216B():1507-14. PubMed ID: 3122535
    [No Abstract]   [Full Text] [Related]  

  • 2. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy.
    Chen N; Nusbaum P; Halbwachs-Mecarelli L; Lesavre P
    Nephrol Dial Transplant; 1991; 6(11):846-50. PubMed ID: 1775249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal antibody dominance after influenza vaccination in IgA nephropathy patients and controls.
    Radl J; Hoogeveen CM; van den Wall Bake AW; Mestecky J
    Adv Exp Med Biol; 1995; 371B():829-34. PubMed ID: 7502907
    [No Abstract]   [Full Text] [Related]  

  • 4. Predominant synthesis of IgA with lambda light chain in IgA nephropathy.
    Lai KN; Chui SH; Lai FM; Lam CW
    Kidney Int; 1988 Feb; 33(2):584-9. PubMed ID: 3129610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune abnormalities of IgA in six families with IgA nephropathy.
    Garcia-Hoyo R; Lozano L; Egido J
    Adv Exp Med Biol; 1987; 216B():1499-505. PubMed ID: 3425442
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential expression of IgA- and IgM-rheumatoid factors in human disease: evidence for independent regulation of rheumatoid factor isotype production.
    Koopman WJ; Schrohenloher RE; Czerkinsky C
    Adv Exp Med Biol; 1987; 216B():1627-39. PubMed ID: 3501236
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary study on specificity of IgA released from lymphocytes by EB virus transformation in patients with IgA nephropathy.
    Tomino Y; Koide H; Yagame M; Sakai H; Tanaka S
    Am J Med Sci; 1990 Jun; 299(6):374-8. PubMed ID: 2162626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal IgA in IgA nephropathy.
    Yasumoto Y; Suga T; Miura M; Nomoto H; Tomino Y; Nomoto Y; Sakai H
    Ann Acad Med Singap; 1988 Jul; 17(3):427-30. PubMed ID: 3146241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to oral polio vaccine in patients with IgA glomerulonephritis.
    Leinikki PO; Mustonen J; Pasternack A
    Clin Exp Immunol; 1987 Apr; 68(1):33-8. PubMed ID: 2820631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge distribution of IgA-lambda in IgA nephropathy.
    Lai KN; Chui SH; Lewis WH; Poon AS; Lam CW
    Nephron; 1994; 66(1):38-44. PubMed ID: 8107951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced IgA production in family members of patients with IgA nephropathy.
    Suga T
    Nihon Jinzo Gakkai Shi; 1985 Sep; 27(9):1239-46. PubMed ID: 4087544
    [No Abstract]   [Full Text] [Related]  

  • 12. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
    Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
    J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of IgA-specific switch T cells in patients with IgA nephropathy.
    Sakai H; Endoh M; Yano N; Kashem A; Nomoto Y
    Contrib Nephrol; 1993; 104():92-8. PubMed ID: 8100756
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte subpopulations and immunoglobulin production in IgA nephropathy.
    Linné T; Wasserman J
    Clin Nephrol; 1985 Mar; 23(3):109-11. PubMed ID: 3157521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo antibody response to mucosal (NASAL) and subcutaneous stimulation of influenza virus in patients with IgA nephropathy.
    Kashem A; Endoh M; Yano N; Yamauchi F; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1992 May; 17(1):23-8. PubMed ID: 1523689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbances of IgA immune regulation in lymphocytes from mucosae and peripheral blood in patients with IgA nephropathy.
    Garcia-Hoyo R; Egido J; Lozano L; de Nicolas R; Hernando L
    Semin Nephrol; 1987 Dec; 7(4):301-5. PubMed ID: 3502191
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase of IgA-specific switch T cells in patients with IgA nephropathy.
    Sakai H; Miyazaki M; Endoh M; Nomoto Y
    Clin Exp Immunol; 1989 Dec; 78(3):378-82. PubMed ID: 2575472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the IgA immune response in peripheral blood and in tonsillar lymphocytes from patients with IgA nephropathy.
    Egido J; Lozano L; Garcia-Hoyo R; de Nicolas R
    Adv Exp Med Biol; 1987; 216B():1523-36. PubMed ID: 2892358
    [No Abstract]   [Full Text] [Related]  

  • 19. IgA nephropathy.
    Béné MC; Faure G
    Springer Semin Immunopathol; 1987; 9(4):387-94. PubMed ID: 3324368
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological studies of IgA nephropathy: familial and racial aspects.
    Julian BA; Wyatt RJ; Waldo FB; Koopman WJ; Jackson S; Schrohenloher RE; Galla JH; Mestecky J; Czerkinsky C
    Adv Exp Med Biol; 1987; 216B():1489-98. PubMed ID: 3425441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.